top of page
Search
Subcutaneous engineered factor VIIa marzeptacog alfa significantly decreases annualized bleed rate
A novel recombinant of human factor VII, marzeptacog alfa (activated) (MarzAA), is a subcutaneous injection engineered to increase...
mcaggianobusiness
Sep 4, 20211 min read
Hemophilia Treatment Market 2026 Forecasts
A Hemophilia industry forecast report has been listed on ResearchandMarkets.com describes the global market size of the Hemophilia...
mcaggianobusiness
Sep 1, 20211 min read


What are bleeds and how do you treat them?
The dangers of Hemophilia come with the spontaneous internal bleeding in life-threatening sites. Life threatening bleeds usually occur in...
mcaggianobusiness
Aug 29, 20211 min read
NEWS
bottom of page
